Phase II study evaluating the efficacy of bevacizumab [Avastin] in hepatocellular carcinoma not amenable to curative treatment
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Bevacizumab (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 22 Oct 2005 New trial record.